SCHEMBL30540239

SCHEMBL30540239

COc1nc(Cl)ncc1-c1ccc(Cl)cc1C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ GAA P10253 1/20 0.43
▸ ERN1 O75460 6/20 0.38
▸ XDH P47989 1/20 0.38
▸ SRC P12931 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ CASP6 P55212 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HPGD P15428 1/20 0.35
▸ PIN1 Q13526 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ CCR4 P51679 2/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26635312 1.00 ALDH1A1 (0.43) ALDH1A1GAAERN1XDHSRC
SCHEMBL30540234 0.82 ERN1 (0.40) ALDH1A1GAAERN1XDHSRC
SCHEMBL26635154 0.82 ERN1 (0.40) ALDH1A1GAAERN1XDHSRC
SCHEMBL30540195 0.81 ERN1 (0.42) ALDH1A1GAAERN1XDHSRC
SCHEMBL26635306 0.81 ERN1 (0.42) ALDH1A1GAAERN1XDHSRC
SCHEMBL8580981 0.76 ALDH1A1 (0.49) ALDH1A1GAAERN1SRCPOLB
SCHEMBL30540219 0.76 NFKB1 (0.40) ERN1XDHTDP1KDM4ESMN1; SMN2
SCHEMBL26635334 0.76 NFKB1 (0.40) ERN1XDHTDP1KDM4ESMN1; SMN2
SCHEMBL30540216 0.74 ERN1 (0.34) ALDH1A1ERN1XDHSRCHPGD
SCHEMBL26635324 0.74 ERN1 (0.34) ALDH1A1ERN1XDHSRCHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116621778-A USP inhibitor, preparation method and application thereof 北京华森英诺生物科技有限公司 2023-08-22 — — CN disclosed
Send feedback